• Tempest Therapeutics appointed Nancy Freda-Smith to its board of directors.
• Freda-Smith will serve as chair of the audit committee.
• She most recently served as chief audit and risk officer at Ralph Lauren.
• Earlier roles include managing director at Deloitte & Touche LLP.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-104034), on September 28, 2026, and is solely responsible for the information contained therein.